BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

685 related articles for article (PubMed ID: 28029168)

  • 1. Trends in Regenerative Medicine: Repigmentation in Vitiligo Through Melanocyte Stem Cell Mobilization.
    Birlea SA; Costin GE; Roop DR; Norris DA
    Med Res Rev; 2017 Jul; 37(4):907-935. PubMed ID: 28029168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repigmentation through Melanocyte Regeneration in Vitiligo.
    Birlea SA; Goldstein NB; Norris DA
    Dermatol Clin; 2017 Apr; 35(2):205-218. PubMed ID: 28317529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Narrow Band Ultraviolet B Treatment for Human Vitiligo Is Associated with Proliferation, Migration, and Differentiation of Melanocyte Precursors.
    Goldstein NB; Koster MI; Hoaglin LG; Spoelstra NS; Kechris KJ; Robinson SE; Robinson WA; Roop DR; Norris DA; Birlea SA
    J Invest Dermatol; 2015 Aug; 135(8):2068-2076. PubMed ID: 25822579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of repigmentation induced by photobiomodulation therapy in vitiligo.
    Yu S; Lan CE; Yu HS
    Exp Dermatol; 2019 Feb; 28 Suppl 1():10-14. PubMed ID: 30698884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glabrous lesional stem cells differentiated into functional melanocytes: new hope for repigmentation.
    Kumar R; Parsad D; Rani S; Bhardwaj S; Srivastav N
    J Eur Acad Dermatol Venereol; 2016 Sep; 30(9):1555-60. PubMed ID: 27538731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repigmentation of Human Vitiligo Skin by NBUVB Is Controlled by Transcription of GLI1 and Activation of the β-Catenin Pathway in the Hair Follicle Bulge Stem Cells.
    Goldstein NB; Koster MI; Jones KL; Gao B; Hoaglin LG; Robinson SE; Wright MJ; Birlea SI; Luman A; Lambert KA; Shellman YG; Fujita M; Robinson WA; Roop DR; Norris DA; Birlea SA
    J Invest Dermatol; 2018 Mar; 138(3):657-668. PubMed ID: 29054607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melanocyte Precursors in the Hair Follicle Bulge of Repigmented Vitiligo Skin Are Controlled by RHO-GTPase, KCTD10, and CTNNB1 Signaling.
    Goldstein NB; Steel A; Barbulescu CC; Koster MI; Wright MJ; Jones KL; Gao B; Ward B; Woessner B; Trottier Z; Pakieser J; Hu J; Lambert KA; Shellman YG; Fujita M; Robinson WA; Roop DR; Norris DA; Birlea SA
    J Invest Dermatol; 2021 Mar; 141(3):638-647.e13. PubMed ID: 32800877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin pigmentation and its control: From ultraviolet radiation to stem cells.
    Yardman-Frank JM; Fisher DE
    Exp Dermatol; 2021 Apr; 30(4):560-571. PubMed ID: 33320376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Micro-Injury Induces Hair Regeneration and Vitiligo Repigmentation Through Wnt/β-Catenin Pathway.
    Han X; Chang L; Qiu Z; Lin M; Wang Y; Liu D; Diao Q; Zhong JL; Xu W
    Stem Cells Dev; 2022 Mar; 31(5-6):111-118. PubMed ID: 35044224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The possible role of Wnt/β-catenin signalling in vitiligo treatment.
    Lin X; Meng X; Lin J
    J Eur Acad Dermatol Venereol; 2023 Nov; 37(11):2208-2221. PubMed ID: 36912722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced Elastin Fibers and Melanocyte Loss in Vitiliginous Skin Are Restored after Repigmentation by Phototherapy and/or Autologous Minigraft Transplantation.
    Hirobe T; Enami H
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of NB-UVB on noncultured melanocyte and keratinocyte transplantation in treatment of generalized vitiligo using two different donor-to-recipient ratios.
    Tawfik YM; Abd Elazim NE; Abdel-Motaleb AA; Mohammed RAA; Tohamy AMA
    J Cosmet Dermatol; 2019 Apr; 18(2):638-646. PubMed ID: 30280485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FK506 promotes melanocyte and melanoblast growth and creates a favourable milieu for cell migration via keratinocytes: possible mechanisms of how tacrolimus ointment induces repigmentation in patients with vitiligo.
    Lan CC; Chen GS; Chiou MH; Wu CS; Chang CH; Yu HS
    Br J Dermatol; 2005 Sep; 153(3):498-505. PubMed ID: 16120133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanocyte destruction and repigmentation in vitiligo: a model for nerve cell damage and regrowth.
    Yu HS
    J Biomed Sci; 2002; 9(6 Pt 2):564-73. PubMed ID: 12432222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolating RNA from precursor and mature melanocytes from human vitiligo and normal skin using laser capture microdissection.
    Goldstein NB; Koster MI; Hoaglin LG; Wright MJ; Robinson SE; Robinson WA; Roop DR; Norris DA; Birlea SA
    Exp Dermatol; 2016 Oct; 25(10):805-11. PubMed ID: 27193292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanocyte-keratinocyte cross-talk in vitiligo.
    Touni AA; Shivde RS; Echuri H; Abdel-Aziz RTA; Abdel-Wahab H; Kundu RV; Le Poole IC
    Front Med (Lausanne); 2023; 10():1176781. PubMed ID: 37275386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The regenerative potential of autologous stem and somatic cells in vitiligo.
    Chanteloube S; Debret R
    Eur J Dermatol; 2024 Feb; 34(1):13-17. PubMed ID: 38557453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt/β-catenin and kit signaling sequentially regulate melanocyte stem cell differentiation in UVB-induced epidermal pigmentation.
    Yamada T; Hasegawa S; Inoue Y; Date Y; Yamamoto N; Mizutani H; Nakata S; Matsunaga K; Akamatsu H
    J Invest Dermatol; 2013 Dec; 133(12):2753-2762. PubMed ID: 23702581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repigmentation of vitiligo-associated leukotrichia after autologous, non-cultured melanocyte-keratinocyte transplantation.
    Al Jasser MI; Ghwish B; Al Issa A; Mulekar SV
    Int J Dermatol; 2013 Nov; 52(11):1383-6. PubMed ID: 23834588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The enigma and challenges of vitiligo pathophysiology and treatment.
    Abdel-Malek ZA; Jordan C; Ho T; Upadhyay PR; Fleischer A; Hamzavi I
    Pigment Cell Melanoma Res; 2020 Nov; 33(6):778-787. PubMed ID: 32198977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.